aap Annual Financial Statements for 2008: Sales +14%, net profit burdened with adjustments

2008: Sales EUR 31.9 million, EBITDA EUR 3.7 million, Net income of the year EUR -5.2 million

aap Implantate AG, a medical technology company listed on the Frankfurt stock exchange achieved in the financial year 2008 a sales growth of 14% to EUR 31.9 million (previous year: EUR 28.0 million).

With a 35% increase in sales compared to the previous year, the Trauma & Orthopaedics division was able to generate an above average growth. The Biomaterials division achieved a sales growth of 4%. Changes in the customers order behavior especially regarding reduction of inventories as well as delays on planned approvals on new products were the reason for the moderate performance in the Biomaterials division.